JP2007509949A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509949A5
JP2007509949A5 JP2006538191A JP2006538191A JP2007509949A5 JP 2007509949 A5 JP2007509949 A5 JP 2007509949A5 JP 2006538191 A JP2006538191 A JP 2006538191A JP 2006538191 A JP2006538191 A JP 2006538191A JP 2007509949 A5 JP2007509949 A5 JP 2007509949A5
Authority
JP
Japan
Prior art keywords
proton
pharmacologically active
active ingredient
composition
accepting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006538191A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509949A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/035540 external-priority patent/WO2005044254A1/en
Publication of JP2007509949A publication Critical patent/JP2007509949A/ja
Publication of JP2007509949A5 publication Critical patent/JP2007509949A5/ja
Withdrawn legal-status Critical Current

Links

JP2006538191A 2003-10-29 2004-10-28 薬理学的に活性な化合物の塩 Withdrawn JP2007509949A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51596703P 2003-10-29 2003-10-29
PCT/US2004/035540 WO2005044254A1 (en) 2003-10-29 2004-10-28 Salts of pharmacologically active compounds

Publications (2)

Publication Number Publication Date
JP2007509949A JP2007509949A (ja) 2007-04-19
JP2007509949A5 true JP2007509949A5 (https=) 2007-11-08

Family

ID=34572865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006538191A Withdrawn JP2007509949A (ja) 2003-10-29 2004-10-28 薬理学的に活性な化合物の塩

Country Status (6)

Country Link
US (1) US20050148519A1 (https=)
EP (1) EP1677781A4 (https=)
JP (1) JP2007509949A (https=)
AU (1) AU2004287439A1 (https=)
CA (1) CA2542509A1 (https=)
WO (1) WO2005044254A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0700969A (pt) * 2007-03-22 2008-11-04 Ouro Fino Participacoes E Empr composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
NZ588686A (en) 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
EP2760433B1 (en) * 2011-09-29 2023-05-31 PLx Opco Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
PL3307275T3 (pl) 2015-06-10 2021-11-02 Piedmont Animal Health Inc. Postacie użytkowe antybiotyków do wstrzykiwania i ich zastosowanie
RU2666607C1 (ru) * 2017-05-03 2018-09-11 Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" Способ повышения стабильности инъекционной фармацевтической композиции
JP2023518822A (ja) 2020-03-26 2023-05-08 ピーエルエックス オプコ インコーポレイテッド pH依存的再構築が可能な医薬キャリア、その製造方法及び使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
JP4642946B2 (ja) * 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
TR199902748T2 (xx) * 1997-05-06 2000-05-22 Norbrook Laboratories Limited Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
US20040033938A1 (en) * 2000-09-12 2004-02-19 Britten Nancy J. Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
WO2003099293A1 (en) * 2002-05-23 2003-12-04 Danmarks Farmaceutiske Universitet Pharmacologically active salts
DE10227938B4 (de) * 2002-06-21 2006-07-20 Heraeus Kulzer Gmbh Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung
CN1856296A (zh) * 2003-09-30 2006-11-01 阿库斯菲尔公司 可注射的、口服、或局部用缓释药物制剂

Similar Documents

Publication Publication Date Title
CN1921865B (zh) 美洛昔康用于治疗猪呼吸系统疾病的用途
ES2492537T3 (es) Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino
CA2430091A1 (en) An antibiotic/analgesic formulation and a method of making this formulation
US20150335598A1 (en) Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
HRP20120639T1 (hr) Fumaratna sol (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
RU2004115103A (ru) Инъецируемые композиции для контролируемоей доставки фармакологически активного соединения
JP2016509067A5 (https=)
JP2010106043A (ja) テトラサイクリンの経口バイオアベイラビリティーを増加する方法
KR102700588B1 (ko) 액체 드레싱 조성물 및 이의 수의학적 용도
JP2010090168A5 (https=)
CA2728727C (en) Pharmaceutical transdermal compositions and method for treating inflammation in cattle
JP2008540394A5 (https=)
JP2007509949A5 (https=)
AR064425A1 (es) Composiciones farmaceuticas y metodo para el tratamiento de la inflamacion en el ganado y en otros animales
JP2002526407A5 (https=)
CN1625411A (zh) Nsaid与pde-4抑制剂的并用药物
JP2014530842A5 (https=)
PL219130B1 (pl) Zastosowanie ketoprofenu
JP2006523723A5 (https=)
CA2522009A1 (en) Methods for the controlled delivery of pharmacologically active compounds
JP2007503433A5 (https=)
RU2019109695A (ru) Лекарственная форма для пролонгированного ослабления симптомов
JP2011507839A5 (https=)
BRPI0413883A (pt) composição e método para a administração de um composto farmacologicamente ativo a um mamìfero
JP2006527169A5 (https=)